EGFR and cancer: Furthermore, CD109 induces EGFR-mediated STAT3 phosphorylation, which supports SCC cell migration, proliferation, and the cancer stem cell phenotype in vitro, suggesting its role in enhancing tumor aggressiveness and inflammation (80).